EUVIMEDEUVIMED entdecken
Crossref

Sialic Acid-Fibronectin–negative and CD-44–positive Pancreatic Cancer Has a Poor Prognosis Due To Epithelial-Mesenchymal Transition

Takeshi Gocho, Hiroshi Takeyama, Yoshinobu Manome, Tomoyuki Tanaka, Michinori Matsumoto, Taro Sakamoto, Takaaki Yamashita, Toru Ikegami

Anticancer Research · 2026

DOI: 10.21873/anticanres.17965 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Takeshi Gocho und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, Jikei University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Pancreatic Neoplasms, Fibronectins, N-Acetylneuraminic Acid.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionPancreatic NeoplasmsFibronectinsN-Acetylneuraminic AcidCarcinoma, Pancreatic DuctalHumansFemalePrognosisMiddle AgedMaleAgedCancer-Associated FibroblastsBiomarkers, TumorVimentinAdult

Stichwörter der Autor:innen

Pancreatic ductal adenocarcinomacancer-associated fibroblastscellular fibronectinepithelial-mesenchymal transitionsialic acid-fibronectin

Substanzen

FibronectinsN-Acetylneuraminic AcidBiomarkers, TumorVimentin

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, Jikei University School of Medicine, Tokyo, Japan.
  • Department of Breast, Thyroid, Endocrine Surgery, Jikei University School of Medicine, Tokyo, Japan; takeyama@jikei.ac.jp.
  • Institute of DNA Sciences, Yokohama, Japan.
  • Department of Breast, Thyroid, Endocrine Surgery, Jikei University School of Medicine, Tokyo, Japan.

Zitieren

APA

Gocho, T., Takeyama, H., Manome, Y., Tanaka, T., Matsumoto, M., Sakamoto, T., Yamashita, T., & Ikegami, T. (2026). Sialic Acid-Fibronectin–negative and CD-44–positive Pancreatic Cancer Has a Poor Prognosis Due To Epithelial-Mesenchymal Transition. Anticancer Research. https://doi.org/10.21873/anticanres.17965

Vancouver

Gocho T, Takeyama H, Manome Y, Tanaka T, Matsumoto M, Sakamoto T, et al. Sialic Acid-Fibronectin–negative and CD-44–positive Pancreatic Cancer Has a Poor Prognosis Due To Epithelial-Mesenchymal Transition. Anticancer Research. 2026. doi:10.21873/anticanres.17965

BibTeX
@article{Gocho2026,
  author = {Gocho, Takeshi and Takeyama, Hiroshi and Manome, Yoshinobu and Tanaka, Tomoyuki and Matsumoto, Michinori and Sakamoto, Taro and Yamashita, Takaaki and Ikegami, Toru},
  title = {Sialic Acid-Fibronectin–negative and CD-44–positive Pancreatic Cancer Has a Poor Prognosis Due To Epithelial-Mesenchymal Transition},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.17965}
}
Kostenlos starten →